Anti-infectives PNLE Questions

Introduction

The live published Tangerine inventory contains exactly 19 original PNLE-style practice questions on Anti-infectives. The inventory was last updated August 12, 2026. These are practice questions, not actual, recalled, or leaked board questions.

Anti-infectives covers antibacterial, antiviral, antifungal, and antiparasitic therapy. The nursing decisions include identifying the likely treatment target, connecting an agent with its purpose, reinforcing safe administration and adherence, recognizing important adverse effects, checking interactions, and distinguishing treatment from preventive infection-control technique. Immunosuppression belongs in Immunologic & Transplant Drugs, while preventive infection-control technique is outside this Pharmacology scope.

Anti-infectives is a Tangerine lens within NP7 Pharmacology. The 2025 Enhanced TOS maps this lens across relevant competencies in the official five-subject PNLE TOS; it is not a separate official test subject. The TOS does not provide a guaranteed question count or standalone weight for this microtopic, and exact microtopic distribution varies by exam form.

Key concepts

Match the anti-infective to the treatment target
Recognize: Antibacterial, antiviral, antifungal, and antiparasitic agents address different pathogen categories. A symptom such as fever does not identify the pathogen by itself.
Decide: Use the indication and stem cues to identify the treatment purpose before selecting an option.
Avoid: Assuming that every infection-like complaint requires an antibacterial drug.
Understand multidrug therapy for active tuberculosis
Recognize: Tuberculosis questions may emphasize combination therapy, a prolonged course, adherence, and monitoring for toxicity or interactions.
Decide: Reinforce the prescribed complete regimen and connect missed doses or self-discontinuation with treatment failure and resistance concerns.
Avoid: Reducing active tuberculosis treatment to one memorized drug or stopping when symptoms improve.
Act on ototoxicity cues
Recognize: Streptomycin-related questions may use tinnitus, hearing changes, or balance symptoms as safety cues.
Decide: Assess the reported change, withhold or continue therapy only according to the authorized order or protocol, and promptly report concerning findings.
Avoid: Reassuring the patient that new auditory or vestibular symptoms are harmless or waiting for severe loss.
Review interactions and patient-specific risks
Recognize: Sulfonamide questions can test interaction checking, allergy history, concurrent medicines, and the need to follow ordered monitoring.
Decide: Reconcile prescribed, over-the-counter, and herbal products, then clarify potentially unsafe combinations before administration.
Avoid: Choosing an answer from the anti-infective name alone while ignoring the medication list.
Identify the purpose of preoperative neomycin
Recognize: When neomycin is linked with preparation before intestinal surgery or an ileostomy, the pharmacologic purpose concerns reducing bacterial burden in the bowel before the procedure.
Decide: Answer from the procedure-related purpose stated in the stem.
Avoid: Confusing a medication’s preoperative purpose with postoperative treatment of a systemic infection or with infection-control technique.
Connect antiviral therapy with its indication
Recognize: Acyclovir questions test recognition of selected viral indications rather than antibacterial coverage.
Decide: Confirm that the infection described matches antiviral therapy and monitor administration, hydration, renal risk, and adverse findings according to the order and protocol.
Avoid: Expecting an antiviral to treat bacterial, fungal, or parasitic disease.
Use organism category and treatment course for fungal and parasitic therapy
Recognize: Antifungal and antiparasitic questions require attention to the organism category, treatment site, route, duration, and response.
Decide: Reinforce the complete prescribed course and assess for therapeutic response or adverse effects relevant to the agent.
Avoid: Applying an antibacterial rule automatically when the stem identifies a fungal or parasitic infection.

What to expect on the PNLE

The inventory supports several single-best-answer forms: identifying an indication, explaining a treatment purpose, recognizing a toxicity, selecting an interaction precaution, interpreting a tuberculosis regimen, and distinguishing the role of a preoperative agent. Read the stem for the pathogen category, treatment setting, patient cue, and requested nursing action before comparing options.

Its live difficulty distribution is 7 easy, 10 medium, and 2 hard. Its Bloom distribution is remembering 12, applying 3, understanding 2, analyzing 1, and evaluating 1, so retrieval of drug purposes and safety associations is prominent, with some items requiring transfer to a clinical cue or judgment about the safest response.

Remembering: retrieve indications, therapy purposes, and named adverse-effect associations.
Understanding: explain why combination therapy or preoperative neomycin is used.
Applying: use an interaction, symptom, or indication cue to select the nursing decision.
Analyzing and evaluating: weigh several cues, prioritize a safety response, or reject an attractive option that does not fit the scope.

This distribution describes the supplied practice inventory, not a prediction of a future exam. Exact topic distribution varies by exam form, and the 2025 Enhanced TOS maps Anti-infectives across relevant competencies rather than assigning it a separate official subject or guaranteed microtopic count.

Study tips

Start with a diagnostic attempt. Answer the Anti-infectives questions without notes, then label each response as certain, uncertain, or guessed. Record whether the difficulty came from pathogen classification, indication, adverse-effect recognition, interaction checking, or regimen reasoning.
Build a focused retrieval grid. Make four columns: agent or class, infection target, key nursing cue, and action or teaching. Add separate rows for antibacterial, antiviral, antifungal, antiparasitic, tuberculosis combination therapy, preoperative neomycin, and the streptomycin ototoxicity cue.
Review the rationale and your error. For every missed item, write one sentence explaining why the correct option fits the stem and why your choice did not. Mark errors caused by confusing treatment with infection-control technique, overlooking an interaction, or choosing a drug name before identifying the indication.
Retry after a gap. Cover the answer column of your grid and retrieve the decisions again in a later study session. Give extra attention to items involving tuberculosis therapy, sulfonamide interactions, neomycin purpose, and acyclovir indications.
Finish with mixed timed practice. Combine Anti-infectives with its adjacent topics, Immunologic & Transplant Drugs, GI & Hepatic Drugs, and Respiratory & Allergy Drugs. After timing ends, review the reasoning process rather than only counting correct answers.

Common mistakes to avoid

Choosing an antibacterial agent because the patient has fever. Fever is a clinical cue, not a pathogen identification. Correct the error by first classifying the infection described and then matching the therapy category to the indication.
Selecting a single tuberculosis drug from a memorized adverse effect. Questions about active tuberculosis may test the purpose of combination therapy and adherence. Look for the complete prescribed regimen and the safety action supported by the stem.
Minimizing tinnitus, hearing change, or dizziness during streptomycin therapy. These findings can signal ototoxicity risk. The safety principle is prompt assessment and reporting, with further medication action guided by the authorized order or protocol.
Ignoring the medication list in a sulfonamide interaction item. An interaction question is solved by checking concurrent medicines, allergy history, and ordered monitoring. Do not select an answer solely because the anti-infective is familiar.
Confusing preoperative neomycin with infection-control technique. The cue of intestinal surgery or ileostomy directs attention to the medication’s preoperative bowel-related purpose. Use Pharmacology reasoning for the drug question and do not substitute a hand-hygiene or isolation intervention.
Using a universal remembered answer for a first-line or antiviral question. The infection, patient context, route, and wording determine the decision. Read the stem for the indication before evaluating a drug option, and avoid inventing a precise regimen when the necessary context is absent.

Try a question

A real Anti-infectives question from our bank. Give it a shot.

Hard

A patient with pulmonary tuberculosis has missed doses and asks to continue only one drug. What is the best response?

A

Assess barriers and coordinate full multidrug therapy with resistance review

B

Provide adherence education and arrange a social work referral for transportation or housing barriers.

C

Substitute a different tuberculosis drug based on tolerance before obtaining resistance testing

D

Resume the original multidrug regimen and monitor for side effects.

Rationale

Tuberculosis (TB) management requires a multidrug regimen to ensure cure, prevent relapse, and avoid the development of drug-resistant Mycobacterium tuberculosis. When a patient misses doses, especially over an extended period, there's an increased risk that the bacteria have developed resistance to first-line drugs. The priority is to halt further resistance and design the safest, most effective regimen.

Option A: Assess barriers and coordinate full multidrug therapy with resistance review

This is the best response because it follows evidence-based nursing practice and World Health Organization (WHO) and Centers for Disease Control (CDC) guidelines for TB management. Before resuming therapy, a nurse must:

Assess why the patient was nonadherent: understanding personal, social, and structural barriers is crucial for preventing future lapses.
Coordinate a plan for restarting multidrug therapy, as single-drug therapy is never indicated for active TB. Using only one drug promotes resistance.
Review for potential drug resistance due to the interruption in therapy. This often involves repeat sputum cultures and drug sensitivity testing before restarting.
Collaborate with the healthcare team, including infectious disease specialists if needed.

This option ensures a comprehensive and safe restart of therapy that addresses both infection control and the patient’s social context.

Option B: Provide adherence education and arrange a social work referral for transportation or housing barriers.

While this option addresses important social determinants of health, it is incomplete. Education and social work referral are vital in promoting adherence but do not address the immediate need to reassess the TB regimen, monitor for resistance, or coordinate multidrug therapy. This response is supportive but not sufficient in a case of missed doses where resistance is possible.

Option C: Substitute a different tuberculosis drug based on tolerance before obtaining resistance testing

Substituting drugs without confirmed sensitivity is dangerous and not evidence-based. TB drugs should never be substituted empirically due to the risk of resistance, especially after lapses in therapy. Drug susceptibility testing guides therapy changes, and nurses should always wait for resistance profiles before altering a regimen.

Option D: Resume the original multidrug regimen and monitor for side effects.

Auto-resuming treatment without assessing for resistance or reasons for nonadherence can fail to address underlying problems and puts the patient (and public) at risk for multidrug-resistant TB. CDC and WHO guidelines specifically warn against restarting defaulted regimens without proper assessment and resistance testing.

Clinical Pearls:

"Never treat TB with a single drug" is a classic memory aid to reinforce the need for multidrug therapy.
Interruptions in TB therapy must prompt assessment for resistance and additional education/support to maximize adherence.
The nurse’s role is critical in bridging clinical judgment and patient-centered care, including social and structural challenges.

Nursing Concept Focus:

Safe, evidence-based medication administration
Infection control and public health
Patient advocacy and interdisciplinary collaboration
Assessment of barriers and individualized care planning

This question tests the candidate’s ability to integrate clinical guidelines and patient-centered reasoning in complex, real-world situations.

World Health Organization. (n.d.). WHO consolidated guidelines on tuberculosis, module 4 treatment. https://www.who.int/publications/i/item/9789240037021
Hinkle, Janice L., Cheever, Kerry H., & Overbaugh, Kristen J. (2022). Brunner & Suddarth's Textbook of Medical-Surgical Nursing (15th ed.). Wolters Kluwer. https://shop.lww.com/Brunner---Suddarth-s-Textbook-of-Medical-Surgical-Nursing/p/9781975161033

References and further reading

PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward.
Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.

How this page is built

The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.

The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.